Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
Plos One
|
March 24, 2015
Mycobacterial dihydrofolate reductase inhibitors identified using chemogenomic methods and in vitro validation
Grace Mugumbate, Katherine A Abrahams, Jonathan A G Cox, et al.
Frontiers in Immunology
|
September 10, 2019
HIV Infection Is Associated With Downregulation of BTLA Expression on <i>Mycobacterium tuberculosis</i>-Specific CD4 T Cells in Active Tuberculosis Disease
Morgan S Barham, Deborah A Abrahams, Jeremiah Khayumbi, et al.
Plos One
|
January 10, 2013
Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB
Katherine A Abrahams, Jonathan A G Cox, Vickey L Spivey, et al.
Scientific Reports
|
August 27, 2017
Inhibiting mycobacterial tryptophan synthase by targeting the inter-subunit interface
Katherine A Abrahams, Jonathan A G Cox, Klaus Fütterer, et al.
Scientific Reports
|
December 17, 2016
Novel inhibitors of Mycobacterium tuberculosis GuaB2 identified by a target based high-throughput phenotypic screen
Jonathan A G Cox, Grace Mugumbate, Laura Vela-Glez Del Peral, et al.
Plos One
|
November 20, 2014
Biochemical and structural characterization of mycobacterial aspartyl-tRNA synthetase AspS, a promising TB drug target
Sudagar S Gurcha, Veeraraghavan Usha, Jonathan A G Cox, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 23, 2006
Bladder cancer. Clinical guidelines in oncology
James E Montie, Neil A Abrahams, Robert R Bahnson, et al.
Nature Microbiology
|
August 31, 2016
THPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteria
Jonathan A G Cox, Katherine A Abrahams, Carlos Alemparte, et al.
Antimicrobial Agents and Chemotherapy
|
May 24, 2022
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective <i>In Vivo</i> with the Potential To Shorten Tuberculosis Treatment
Eric L Nuermberger, Maria Santos Martínez-Martínez, Olalla Sanz, et al.
Nature Communications
|
September 2, 2016
Identification of KasA as the cellular target of an anti-tubercular scaffold
Katherine A Abrahams, Chun-Wa Chung, Sonja Ghidelli-Disse, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
Plos One
|
March 24, 2015
Mycobacterial dihydrofolate reductase inhibitors identified using chemogenomic methods and in vitro validation
Grace Mugumbate, Katherine A Abrahams, Jonathan A G Cox, et al.
Frontiers in Immunology
|
September 10, 2019
HIV Infection Is Associated With Downregulation of BTLA Expression on <i>Mycobacterium tuberculosis</i>-Specific CD4 T Cells in Active Tuberculosis Disease
Morgan S Barham, Deborah A Abrahams, Jeremiah Khayumbi, et al.
Plos One
|
January 10, 2013
Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB
Katherine A Abrahams, Jonathan A G Cox, Vickey L Spivey, et al.
Scientific Reports
|
August 27, 2017
Inhibiting mycobacterial tryptophan synthase by targeting the inter-subunit interface
Katherine A Abrahams, Jonathan A G Cox, Klaus Fütterer, et al.
Scientific Reports
|
December 17, 2016
Novel inhibitors of Mycobacterium tuberculosis GuaB2 identified by a target based high-throughput phenotypic screen
Jonathan A G Cox, Grace Mugumbate, Laura Vela-Glez Del Peral, et al.
Plos One
|
November 20, 2014
Biochemical and structural characterization of mycobacterial aspartyl-tRNA synthetase AspS, a promising TB drug target
Sudagar S Gurcha, Veeraraghavan Usha, Jonathan A G Cox, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 23, 2006
Bladder cancer. Clinical guidelines in oncology
James E Montie, Neil A Abrahams, Robert R Bahnson, et al.
Nature Microbiology
|
August 31, 2016
THPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteria
Jonathan A G Cox, Katherine A Abrahams, Carlos Alemparte, et al.
Antimicrobial Agents and Chemotherapy
|
May 24, 2022
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective <i>In Vivo</i> with the Potential To Shorten Tuberculosis Treatment
Eric L Nuermberger, Maria Santos Martínez-Martínez, Olalla Sanz, et al.
Nature Communications
|
September 2, 2016
Identification of KasA as the cellular target of an anti-tubercular scaffold
Katherine A Abrahams, Chun-Wa Chung, Sonja Ghidelli-Disse, et al.
Page
of 10